Aptorum Group (Aptorum Group) Price-to-Operating-Cash-Flow : (As of Apr. 28, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Price-to-Operating-Cash-Flow?

As of today (2024-04-28), Aptorum Group's share price is $5.28. Aptorum Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.12. Hence, Aptorum Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Aptorum Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

APM's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Aptorum Group's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $-1.61. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.12.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.20% per year.

During the past 6 years, Aptorum Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 9.20% per year. The lowest was -5.20% per year. And the median was 2.00% per year.

Aptorum Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Aptorum Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Price-to-Operating-Cash-Flow Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Aptorum Group's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Aptorum Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptorum Group's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Price-to-Operating-Cash-Flow falls into.

Aptorum Group Price-to-Operating-Cash-Flow Calculation

Aptorum Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.28	/	-3.123
	=

Aptorum Group's Share Price of today is $5.28.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.12.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Aptorum Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.